Cargando…

Sustained reduction in rotavirus-coded hospitalizations in children aged <5 years after introduction of self-financed rotavirus vaccines in Japan

This is an extension of our previous study, which evaluated the incidence of seasonal rotavirus gastroenteritis (RVGE) hospitalizations in children aged <5 years from 2009 to 2015 in Japan. Here, we evaluated the incidence of RVGE hospitalizations in children aged <10 years during the rotaviru...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Masayuki, Miyazaki, Makoto, Ogawa, Akira, Tatsumi, Masatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012068/
https://www.ncbi.nlm.nih.gov/pubmed/31298962
http://dx.doi.org/10.1080/21645515.2019.1638204
_version_ 1783496186284474368
author Kobayashi, Masayuki
Miyazaki, Makoto
Ogawa, Akira
Tatsumi, Masatoshi
author_facet Kobayashi, Masayuki
Miyazaki, Makoto
Ogawa, Akira
Tatsumi, Masatoshi
author_sort Kobayashi, Masayuki
collection PubMed
description This is an extension of our previous study, which evaluated the incidence of seasonal rotavirus gastroenteritis (RVGE) hospitalizations in children aged <5 years from 2009 to 2015 in Japan. Here, we evaluated the incidence of RVGE hospitalizations in children aged <10 years during the rotavirus season (January‒June) from 2009 to 2017 in Japan, before and after the monovalent and pentavalent rotavirus vaccines were introduced in November 2011 and July 2012, using the same health insurance claims database and study methods. In children aged <5 years, the incidence of RVGE hospitalizations greatly declined in 2014 after vaccine introduction, consistent with our previous findings, and the decline was sustained until 2017. However, in children aged ≥5‒<10 years, no apparent trend for a continuous decline in RVGE hospitalizations was observed during the study period. Improved RV vaccination coverage may lead to a further reduction in severe RVGE in Japan.
format Online
Article
Text
id pubmed-7012068
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-70120682020-02-24 Sustained reduction in rotavirus-coded hospitalizations in children aged <5 years after introduction of self-financed rotavirus vaccines in Japan Kobayashi, Masayuki Miyazaki, Makoto Ogawa, Akira Tatsumi, Masatoshi Hum Vaccin Immunother Research Paper This is an extension of our previous study, which evaluated the incidence of seasonal rotavirus gastroenteritis (RVGE) hospitalizations in children aged <5 years from 2009 to 2015 in Japan. Here, we evaluated the incidence of RVGE hospitalizations in children aged <10 years during the rotavirus season (January‒June) from 2009 to 2017 in Japan, before and after the monovalent and pentavalent rotavirus vaccines were introduced in November 2011 and July 2012, using the same health insurance claims database and study methods. In children aged <5 years, the incidence of RVGE hospitalizations greatly declined in 2014 after vaccine introduction, consistent with our previous findings, and the decline was sustained until 2017. However, in children aged ≥5‒<10 years, no apparent trend for a continuous decline in RVGE hospitalizations was observed during the study period. Improved RV vaccination coverage may lead to a further reduction in severe RVGE in Japan. Taylor & Francis 2019-08-01 /pmc/articles/PMC7012068/ /pubmed/31298962 http://dx.doi.org/10.1080/21645515.2019.1638204 Text en © 2019 Merck Sharp & Dohme Corp. Published with license by Taylor & Francis Group, LLC https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Research Paper
Kobayashi, Masayuki
Miyazaki, Makoto
Ogawa, Akira
Tatsumi, Masatoshi
Sustained reduction in rotavirus-coded hospitalizations in children aged <5 years after introduction of self-financed rotavirus vaccines in Japan
title Sustained reduction in rotavirus-coded hospitalizations in children aged <5 years after introduction of self-financed rotavirus vaccines in Japan
title_full Sustained reduction in rotavirus-coded hospitalizations in children aged <5 years after introduction of self-financed rotavirus vaccines in Japan
title_fullStr Sustained reduction in rotavirus-coded hospitalizations in children aged <5 years after introduction of self-financed rotavirus vaccines in Japan
title_full_unstemmed Sustained reduction in rotavirus-coded hospitalizations in children aged <5 years after introduction of self-financed rotavirus vaccines in Japan
title_short Sustained reduction in rotavirus-coded hospitalizations in children aged <5 years after introduction of self-financed rotavirus vaccines in Japan
title_sort sustained reduction in rotavirus-coded hospitalizations in children aged <5 years after introduction of self-financed rotavirus vaccines in japan
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012068/
https://www.ncbi.nlm.nih.gov/pubmed/31298962
http://dx.doi.org/10.1080/21645515.2019.1638204
work_keys_str_mv AT kobayashimasayuki sustainedreductioninrotaviruscodedhospitalizationsinchildrenaged5yearsafterintroductionofselffinancedrotavirusvaccinesinjapan
AT miyazakimakoto sustainedreductioninrotaviruscodedhospitalizationsinchildrenaged5yearsafterintroductionofselffinancedrotavirusvaccinesinjapan
AT ogawaakira sustainedreductioninrotaviruscodedhospitalizationsinchildrenaged5yearsafterintroductionofselffinancedrotavirusvaccinesinjapan
AT tatsumimasatoshi sustainedreductioninrotaviruscodedhospitalizationsinchildrenaged5yearsafterintroductionofselffinancedrotavirusvaccinesinjapan